Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Market Cap	96.95B -8.4%
Revenue (ttm)	75.40B +10.6%
Net Income	7.97B +52.2%
EPS	81.37 +52.2%
Shares Out	97.90M
PE Ratio	12.17
Forward PE	11.04
Dividend	40.00 (4.04%)
Ex-Dividend Date	Apr 22, 2026

Volume	157,733
Average Volume	50,716
Open	986.00
Previous Close	976.45
Day's Range	961.30 - 1,000.00
52-Week Range	790.00 - 1,304.00
Beta	0.22
RSI	57.52
Earnings Date	Apr 28, 2026

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; AND import and marketing of nutritional products. It imports and markets diagnostic equipment, molecu...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1888
• Employees: 1,380
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: ABOT

Financial Performance

In 2025, PSX:ABOT's revenue was 75.40 billion, an increase of 10.59% compared to the previous year's 68.18 billion. Earnings were 7.97 billion, an increase of 52.20%.